Literature DB >> 27318047

Fiber type as compared to wavelength may contribute more to improving postoperative recovery following endovenous laser ablation.

Lowell S Kabnick1, Mikel Sadek2.   

Abstract

OBJECTIVE: To define the relative importance of fiber type as compared to laser wavelength on tissue injury depth, postoperative pain, and bruising during endovenous laser ablation.
METHODS: This study included 213 limbs that were treated with an 810-, 980-, or 1470-nm laser, with bare-tip (BT) or jacket-tip (JT) fibers. Pain scores (10-point scale) and bruising scores (5-point scale) were recorded. Tissue thermal injury depth (mm) was evaluated in vitro for the 810- and 1470-nm wavelengths with BT and JT fibers.
RESULTS: The JT fibers had lower pain scores as compared to the BT fibers at 810 nm (1.69 ± 1.77 vs 3.70 ± 1.34; P < .0005) and at 980 nm (1.14 ± 1.06 vs 2.71 ± 1.80; P < .0005). The JT fibers had lower bruising scores as compared to the BT fibers at 980 nm (0.89 ± 1.06 vs 2.00 ± 1.44; P < .0005). The in vitro study showed lower thermal injury depths for the JT as compared to the BT fibers at 810 nm (0.36 mm ± 0.26 mm vs 1.05 mm ± 0.34 mm; P < .0005) and at 1470 nm (0.20 ± 0.16 mm vs 0.71 ± 0.31 mm; P < .0005). With regard to wavelength, 980-nm laser had lower pain scores as compared to 810-nm laser with BT fibers (2.71 ± 1.80 vs 3.70 ± 1.34; P = .015), and with JT fibers, a similar result trended toward significance (1.14 ± 1.06 vs 1.69 ± 1.77; P = .057). The 980-nm JT fiber showed less bruising as compared to the 810-nm JT fiber (0.89 ± 1.06 vs 1.42 ± 1.19; P = .019). Similarly, the 1470-nm JT fiber showed less bruising as compared to the 810-nm JT fiber (0.94 ± 1.02 vs 1.42 ± 1.19; P = .038). The in vitro study showed thermal injury depths that were less for 1470 nm as compared to 810 nm, with JT fibers (0.20 ± 0.16 mm vs 0.36 ± 0.26 mm; P = .013) or with BT fibers (0.71 ± 0.31 mm vs 1.05 ± 0.34 mm; P =.001). All mean differences between JT and BT fibers were greater than between differing wavelengths. The multivariate analysis for the in vitro study showed a mean difference between 1470 nm and 810 nm of 0.26 mm, P < .0005 favoring 1470 nm and a mean difference between JT and BT fibers of 0.61 mm, P < .0005 favoring the JT fibers.
CONCLUSIONS: The use of a JT fiber appeared to be more significant in reducing pain and bruising as compared to a longer wavelength. Moreover, the results appeared additive, and the cohort using 1470 nm with a JT fiber produced the best treatment outcomes. Additional study is required to confirm the efficacy and durability of the various iterations evaluated; however, these data should be taken into consideration when undertaking treatment with endovenous laser ablation.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27318047     DOI: 10.1016/j.jvsv.2015.12.004

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  4 in total

1.  Comparison of synchronous dual wavelength diode laser versus conventional endo-knives for esophageal endoscopic submucosal dissection: an animal study.

Authors:  Jian Tang; Shufang Ye; Xueliang Ji; Jun Li; Feng Liu
Journal:  Surg Endosc       Date:  2018-08-16       Impact factor: 4.584

Review 2.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

3.  In Situ Laser Fenestration Is a Feasible Method for Revascularization of Aortic Arch During Thoracic Endovascular Aortic Repair.

Authors:  Jinbao Qin; Zhen Zhao; Ruihua Wang; Kaichuang Ye; Weimin Li; Xiaobing Liu; Guang Liu; Chaoyi Cui; Huihua Shi; Zhiyou Peng; Fukang Yuan; Xinrui Yang; Min Lu; Xintian Huang; Mier Jiang; Xin Wang; Minyi Yin; Xinwu Lu
Journal:  J Am Heart Assoc       Date:  2017-04-21       Impact factor: 5.501

Review 4.  Latest Innovations in the Treatment of Venous Disease.

Authors:  Robert R Attaran
Journal:  J Clin Med       Date:  2018-04-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.